During the past decade, TSE-HUNG HUANG MD PhD conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "TSE-HUNG HUANG MD PhD" #1 collaborator was "Ministry of Health and Welfare" with 1 trials as a collaborator and "Zhao Hong Biotechnology Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "TSE-HUNG HUANG MD PhD" are "Dietary Supplement" (1 trials), "Glucose Metabolism Disorders" (1 trials), "Metabolic Diseases" (1 trials), "Nutrition" (1 trials) and "Prediabetes" (1 trials). Many other conditions were trialed in "TSE-HUNG HUANG MD PhD" in a lesser frequency.

Most popular intervention types in "TSE-HUNG HUANG MD PhD" are "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Clam peptide plus Chlorella capsules" (1 trials), "Laser acupuncture" (1 trials), "Placebo" (1 trials) and "clam protein capsules" (1 trials). Other intervention names were less common.

The vast majority of trials in "TSE-HUNG HUANG MD PhD" are 2 trials for "All" genders.

Currently, there are NaN active trials in "TSE-HUNG HUANG MD PhD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in TSE-HUNG HUANG MD PhD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in TSE-HUNG HUANG MD PhD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".